NYSE: CHEChemed Corp Stock
$573.34-44.61 (-7.22%)
Updated Apr 25, 2024
Chemed shares are trading lower... find out Why CHE Price Moved with a free WallStreetZen account
Why Price MovedCHE Price
$573.34
Fair Value Price
N/A
Market Cap
$8.67B
52 Week Low
$492.84
52 Week High
$654.62
P/E
31.66x
P/B
7.82x
P/S
3.89x
PEG
1.62x
Dividend Yield
0.28%
Revenue
$2.26B
Earnings
$272.51M
Gross Margin
35.3%
Operating Margin
15.61%
Profit Margin
12%
Debt to Equity
0.51
Operating Cash Flow
$330M
Beta
0.69
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CHE Overview
Chemed Corporation participates in two distinct lines of business. Its VITAS Healthcare segment provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the U.S. Its Roto-Rooter segment offers plumbing, drain cleaning, excavation, water restoration, and related services to residential and commercial customers. The company was incorporated in 1970 and is headquartered in Cincinnati, OH.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CHE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CHE ($573.34) is trading above its intrinsic value of $223.03, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CHE is good value based on its earnings relative to its share price (31.66x), compared to the US market average (40.97x)
P/E vs Market Valuation
CHE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CHE due diligence checks available for Premium users.
Be the first to know about important CHE news, forecast changes, insider trades & much more!
CHE News
Valuation
CHE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
31.66x
Industry
-0.78x
Market
40.97x
CHE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CHE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CHE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.82x
Industry
4.54x
CHE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CHE price to earnings growth (PEG)
For valuing profitable companies with growth potential
CHE is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CHE's financial health
Profit margin
Revenue
$585.9M
Net Income
$90.1M
Profit Margin
15.4%
CHE's Earnings (EBIT) of $353.48M... subscribe to Premium to read more.
Interest Coverage Financials
CHE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7B
Liabilities
$560.2M
Debt to equity
0.51
CHE's short-term assets ($500.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CHE's short-term assets ($500.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CHE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CHE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$108.6M
Investing
-$11.7M
Financing
-$6.1M
CHE's operating cash flow ($330.30M)... subscribe to Premium to read more.
Debt Coverage Financials
CHE vs Medical Care Facility Stocks
Chemed Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.